+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

China NT Pharma Group Co Ltd (1011) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 38 Pages
  • February 2023
  • Region: China
  • GlobalData
  • ID: 4319045
China NT Pharma Group Co Ltd (1011) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

China NT Pharma Group Co Ltd (NT Pharma) is a technology-based and scientific pharmaceutical company, which research, develops, manufactures and distributes branded and generic pharmaceuticals. The company also promotes and distributes drugs manufactured by third parties. It develops drugs for indications such as cancer; central nervous system disorders; orthopedics; hepatopathy and respiratory disorders. NT Pharma's branded products include Xi Di Ke for the treatment of various cancers; Miacalcic for bone pain; Shusi, an antipsychotic drug; Zhuo'ao, a respiratory drug, and Songzhi Wan, a traditional Chinese medicine for the treatment of Hepatitis C. The company operates three production bases for chemical drugs, traditional Chinese medicine and bio-chemical drugs through its subsidiaries, Suzhou First, Jiangsu Biopharma and Changsha Pharma. NT Pharma is headquartered in Sheung Wan, Hong Kong.

China NT Pharma Group Co Ltd Key Recent Developments

  • Sep 29, 2022: China NT Pharma Group Co Ltd announced interim report for 2022
  • May 30, 2022: China NT Pharma Group Co Ltd announced annual report 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • China NT Pharma Group Co Ltd - Key Facts
  • China NT Pharma Group Co Ltd - Key Employees
  • China NT Pharma Group Co Ltd - Key Employee Biographies
  • China NT Pharma Group Co Ltd - Major Products and Services
  • China NT Pharma Group Co Ltd - History
  • China NT Pharma Group Co Ltd - Company Statement
  • China NT Pharma Group Co Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • China NT Pharma Group Co Ltd - Business Description
  • R&D Overview
  • China NT Pharma Group Co Ltd - Corporate Strategy
  • China NT Pharma Group Co Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • China NT Pharma Group Co Ltd - Strengths
  • China NT Pharma Group Co Ltd - Weaknesses
  • China NT Pharma Group Co Ltd - Opportunities
  • China NT Pharma Group Co Ltd - Threats
  • China NT Pharma Group Co Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • China NT Pharma Group Co Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Sep 29, 2022: China NT Pharma Group Co Ltd announced interim report for 2022
  • May 30, 2022: China NT Pharma Group Co Ltd announced annual report 2021
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • China NT Pharma Group Co Ltd, Key Facts
  • China NT Pharma Group Co Ltd, Key Employees
  • China NT Pharma Group Co Ltd, Key Employee Biographies
  • China NT Pharma Group Co Ltd, Major Products and Services
  • China NT Pharma Group Co Ltd, History
  • China NT Pharma Group Co Ltd, Other Locations
  • China NT Pharma Group Co Ltd, Subsidiaries
  • China NT Pharma Group Co Ltd, Key Competitors
  • China NT Pharma Group Co Ltd, Annual Ratios
  • China NT Pharma Group Co Ltd, Interim Ratios
  • China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • China NT Pharma Group Co Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • China NT Pharma Group Co Ltd, Performance Chart (2017 - 2021)
  • China NT Pharma Group Co Ltd, Ratio Charts
  • China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Chengdu Kanghua Biological Products Co Ltd
  • Sumitomo Pharmaceuticals (Suzhou) Co Ltd
  • Beijing Tiantan Biological Products Co Ltd
  • Anhui Anke Biotechnology (Group) Co Ltd
  • Beijing Beilu Pharmaceutical Co Ltd
  • Beijing SL Pharmaceutical Co Ltd
  • Zhejiang Hisun Pharmaceutical Co Ltd